Skip to main content
. 2016 Mar 18;23(6):915–926. doi: 10.1038/cdd.2015.172

Table 3. Components of the autophagic machinery and their association with inflammatory and autoimmune diseases.

Molecule Confirmed pathway(s) Associated Disease(s) References
NOX2 LAP CGD, Alzheimer's disease, Creuzfeldt–Jakob disease 165, 166, 167
Rubicon LAP Ataxia 168
Beclin1 Autophagy LAP Ovarian cancer, breast cancer, lung cancer, cystic fibrosis, Alzheimer's disease, RA 169, 170, 171, 172, 173, 174
VPS34 Autophagy LAP Schizophrenia 175
UVRAG Autophagy LAP Stomach cancer, non-segmental vitiligo, colorectal cancer, cardiomyopthay 85, 176, 177, 178
ATG5 Autophagy LAP Airway inflammation, SLE/systemic autoimmunity, MS/EAE, RA, Alzheimer's disease, atherosclerosis 179, 180, 181, 182, 183, 184
ATG16L Autophagy LAP Crohn's disease, atheroclerosis 185, 186
ATG7 Autophagy LAP SLE/systemic autoimmunity, MS/EAE, type I diabetes, RA, Alzheimer's disease, cardiomyopathy 187, 188, 189, 190
ATG4 Autophagy LAP Otoconia 191
LC3 Autophagy LAP Nasu-Hakola disease 192
LAMP2 Autophagy LAP Danon disease, type II diabetes 193
ULK1 Autophagy Crohn's disease 194
FIP200 Autophagy Inflammatory skin disorders 195
p62 Autophagy Huntingtin's disease 196
EPG5 Autophagy Vici syndrome 197
IRGM Autophagy Crohn's disease, MS/EAE 198
SMURF1 Autophagy Ulcerative colitis 199
WDR45 Autophagy Encephalopathy 200
Parkin Mitophagy Parkinson's disease 201
PINK1 Mitophagy Parkinson's disease 202

Abbreviations: ATG, autophagy-related gene; CGD, chronic granulomatous disease; EAE, experimental autoimmune encephalitis; LAP, LC3-associated phagocytosis; MS, Multiple sclerosis; RA, rheumatoid arthritis; SLE, systemic lupus erythematosus

Confirmed activity in autophagy, LAP, and/or mitophagy is indicated